Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Water Sci Technol ; 83(7): 1764-1780, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33843758

ABSTRACT

Hospital wastewaters are produced in large volumes in Pakistan (∼362-745 L/bed.day) and are discharged without proper treatment. They are widely used by farmers for crop irrigation and induce a phytotoxic effect on plant growth. The study was conducted to evaluate the effect of untreated and treated hospital wastewater on seed germination of a fodder crop Trifolium alexandrinum (Berseem clover) and a food crop Solanum lycopersicum (tomato). A bacterial consortium was formed with three bacterial strains, i.e., Alcaligenes faecalis and Bacillus paramycoides spp., which were individually proven efficient in previous studies. The concentrations of untreated and treated hospital wastewater (25, 50, 75 and 100%) were used to irrigate these crop seeds. To assess the efficiency of treatment, the germination percentage, delay index, germination index, stress tolerance indices, seedling vigour index and phytotoxicity index were calculated and were statistically proven significant. The seeds grown in treated wastewater concentrations showed negative values of phytotoxicity indices (tomato: -0.36, -0.47, -0.78 and -1.11; Berseem clover: -0.23) which indicate a stimulatory or non-toxic effect on seedling growth. Our work proposes that this bacterial consortium is efficient for hospital wastewater treatment before crop irrigation.


Subject(s)
Alcaligenes faecalis , Solanum lycopersicum , Trifolium , Bacillus , Germination , Hospitals , Medicago , Seeds , Wastewater
2.
Ultrasound Obstet Gynecol ; 48(4): 476-482, 2016 Oct.
Article in English | MEDLINE | ID: mdl-26690832

ABSTRACT

OBJECTIVE: To present a single center experience of a standardized prenatal multidisciplinary management protocol for fetal lower urinary tract obstruction (LUTO) and to propose a classification of fetal LUTO based on disease severity. METHODS: This was a retrospective cohort study of 25 consecutive fetal patients with prenatal diagnosis of primary LUTO. Fetal intervention was offered after evaluation by a multidisciplinary team. Analyses were conducted using Bayesian methodology to determine predictors of survival at 6 months postpartum. Odds ratios (ORs) with 95% credibility intervals are reported. RESULTS: Fifteen (60.0%) of the 25 patients referred for assessment survived to postnatal evaluation. Fetal vesicoamniotic shunt was placed in 14 (56.0%) patients with 12 survivors. Multivariable analysis suggested that fetal intervention (OR, 6.97 (0.88-70.16), Pr(OR > 1) = 96.7%), anhydramnios (OR, 0.12 (0.04-0.35), Pr(OR < 1) = 99.9%), favorable fetal urine analysis (OR, 3.98 (0.63-25.15), Pr(OR > 1) = 92.7%) and absence of renal cortical cysts (OR, 3.9 (0.66-24.2), Pr(OR > 1) = 93.3%) were predictors of survival. CONCLUSIONS: Fetal intervention and fetal renal function were independently associated with postnatal survival of fetuses with LUTO. A classification based on the severity of disease is proposed. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.


Subject(s)
Cystoscopy/methods , Fetal Diseases/surgery , Prenatal Care/methods , Urinary Bladder Neck Obstruction/surgery , Bayes Theorem , Disease Management , Female , Fetal Diseases/diagnosis , Humans , Kidney Function Tests , Pregnancy , Prognosis , Retrospective Studies , Survival Analysis , Treatment Outcome , Urinary Bladder Neck Obstruction/diagnosis
3.
Med Mycol Case Rep ; 42: 100599, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37727452

ABSTRACT

We present a case of laryngeal cryptococcosis caused by cryptococcosis neoformans var. grubii affecting a patient using excessive inhaled corticosteroids. The patient experienced symptoms for several months prior to specialist review and the visualization of a mass lesion by nasopharyngoscopy. Fortunately a biopsy was performed and through histopathology & microbiological assessment a diagnosis of cryptococcal laryngitis was made. Treatment with 6 months of fluconazole resulted in clinical cure and resolution of symptoms. It is important to raise awareness of the risk of non-Candida fungal infections in patients on high dose corticosteroids, especially in the post covid era were steroids are more commonly prescribed.

4.
Cureus ; 15(8): e43199, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37692609

ABSTRACT

The formation of an intradural extramedullary arachnoid cyst is a rare complication of spinal anesthesia. We present a case of a 34-year-old female patient who developed neurological symptoms including a bilateral reduction in sensation and strength in the lower limbs following a C-section under spinal anesthesia. MRI of the thoracic spine revealed a lesion at the level of T11/T12 and the upper limit of the L1 vertebral body, which was pushing the cord to the side, and a diagnosis of the intradural extramedullary arachnoid cyst was established. The prognosis for this condition is good and surgical excision leads to resolution of the symptoms. Proper and prompt diagnosis is crucial to rule out other differentials and prevent permanent neurological damage in these patients.

5.
Cureus ; 15(3): e36276, 2023 Mar.
Article in English | MEDLINE | ID: mdl-37073206

ABSTRACT

Background Basal cell carcinoma (BCC) is one of the most common types of cutaneous malignancies and the most frequently occurring form of cancer worldwide. The incidence of basal cell carcinoma is difficult to determine due to its wide geographic variations; however, it has been increasing worldwide with an annual increase of 7% in the number of reported cases. Although BCC is more prevalent in the aging population, diagnosis in younger individuals is steadily increasing. BCC has overall low mortality, however, it leads to significant economic and physical impact on patients and their families along with adding burden to the healthcare system. The primary risk factor for the development of BCC is increased cumulative sun exposure, particularly to UV radiation. The UV index of Karachi averages around 12 (extremely high) during summer months, putting the population at a significantly higher risk of developing BCC in the long term. Objectives This audit was undertaken with the following primary objectives: to use the data collected to determine possible prognostic factors for BCC, to measure the rate of recurrence and the number of new primary tumors detected, to study the completeness of follow-up by patients, and to co-relate histopathological findings with the recurrence rate of basal cell carcinoma. Methods A retrospective analysis was performed for all patients with BCC who had undergone surgical resection over a six-year time period. Patient charts were reviewed for demographic information, tumor size, onset-to-diagnosis, anatomic location, clinical subtype, histologic differentiation, method of surgical treatment, and recurrence. Data were entered and analyzed in SPSS version 23 (IBM Corp., Armonk, NY). Results The review identified cases of BCC in 99 patients. Of the 99 patients, 60.39% were men and 38.38% were women. The most frequent age group was 65-85-year-olds (42 patients, 42.85%) for BCC. Based on the aesthetic units of the face, the most common location was the nasal unit (30 cases, 30.30%) for BCC. Most of the lesions were closed primarily; however; local flaps were used in the case of surgical defects. The recurrence rate was 19.19% for BCC in this study. Our study included 1.0% of patients who were classified as Clark classification level 2 of BCC, 6.1% as Clark level 3, 23.4% as Clark level 4, and 0.16% as Clark level 5. Recurrence rates were seen to increase with increasing Clark classification level in this study. Conclusion In our study, many characteristics of BCC were compared to previously published reports and the results were seen to be generally similar. This study correlates the recurrence of BCC with Clark's classification, showing that depth of invasion is a significant factor in predicting recurrence. There is a paucity of literature regarding the depth of invasion of BCC along with its' Clarks classification and recurrence. Further studies can help explore and establish the characteristics of BCC.

6.
Mol Ecol ; 21(8): 1951-65, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22250784

ABSTRACT

Diet analysis is a prerequisite to fully understand the biology of a species and the functioning of ecosystems. For carnivores, traditional diet analyses mostly rely upon the morphological identification of undigested remains in the faeces. Here, we developed a methodology for carnivore diet analyses based on the next-generation sequencing. We applied this approach to the analysis of the vertebrate component of leopard cat diet in two ecologically distinct regions in northern Pakistan. Despite being a relatively common species with a wide distribution in Asia, little is known about this elusive predator. We analysed a total of 38 leopard cat faeces. After a classical DNA extraction, the DNA extracts were amplified using primers for vertebrates targeting about 100 bp of the mitochondrial 12S rRNA gene, with and without a blocking oligonucleotide specific to the predator sequence. The amplification products were then sequenced on a next-generation sequencer. We identified a total of 18 prey taxa, including eight mammals, eight birds, one amphibian and one fish. In general, our results confirmed that the leopard cat has a very eclectic diet and feeds mainly on rodents and particularly on the Muridae family. The DNA-based approach we propose here represents a valuable complement to current conventional methods. It can be applied to other carnivore species with only a slight adjustment relating to the design of the blocking oligonucleotide. It is robust and simple to implement and allows the possibility of very large-scale analyses.


Subject(s)
DNA Barcoding, Taxonomic/methods , DNA, Mitochondrial/genetics , Felidae/physiology , Predatory Behavior , RNA, Ribosomal/genetics , Sequence Analysis, DNA/methods , Animals , Behavior, Animal , DNA, Mitochondrial/analysis , Diet , Feces/chemistry , Oligonucleotides/genetics , Species Specificity
7.
Eur J Clin Microbiol Infect Dis ; 31(8): 1883-7, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22198679

ABSTRACT

Patients with pulmonary nontuberculous mycobacteriosis (pNTM) may have suboptimum response to conventional antimicrobial therapy. Aerosolized amikacin (aeAmk) was given to nine patients who had failed standard combination oral antimycobacterial drugs. A favorable toxicity profile, even in patients given aeAmk for an extended duration, median 75 ± 85 (range, 18-277) days and total cumulative dose 35,400 ± 30,568 (range, 7,600-95,400) mg, was encouraging, as was the clinical response and resolution of symptoms in 8 of 9 patients. The patient who failed therapy died due to complications arising from prior hematopoietic transplantation. The feasibility and efficacy of aeAmk in combination with oral anti-NTM drug(s) for treatment-refractory disease and, importantly, in primary therapy for pNTM requires validation randomized trials.


Subject(s)
Aerosols/administration & dosage , Amikacin/administration & dosage , Anti-Bacterial Agents/administration & dosage , Mycobacterium Infections, Nontuberculous/drug therapy , Pneumonia, Bacterial/drug therapy , Aerosols/adverse effects , Aged , Amikacin/adverse effects , Anti-Bacterial Agents/adverse effects , Female , Humans , Male , Middle Aged , Treatment Outcome
8.
Environ Technol ; 43(12): 1903-1916, 2022 May.
Article in English | MEDLINE | ID: mdl-33342352

ABSTRACT

Farmers near towns and cities are using a wide range of highly polluted wastewaters for crop irrigation in Pakistan due to severe freshwater shortage. The present study aimed to promote indigenous bacterial strains isolated from domestic, hospital, textile, pharmaceutical and mixed wastewaters to remove contaminants and colour and render these wastewaters safer for irrigation. Thirty seven bacterial strains were isolated from five wastewater samples collected from different sites in Lahore, Pakistan. Under optimal growth conditions, three isolates (D6, D7 and P1) showed >93% decolourisation potential in the treatment of hospital wastewater. 16S rDNA sequencing identified two of these isolates (D6 and D7) as showing 100% and 99.86% homology to Bacillus paramycoides spp. - novel strains from B. cereus group. Isolate P1 showed 97.47% homology to Alcaligenes faecalis. GCMS analysis of the untreated hospital wastewater revealed the presence of pharmaceutic pollutants, i.e. Phenol (876 µg/L), Salicylic acid (48 µg/L), Caffeine (7 µg/L), Naproxen (23 µg/L), Octadecene (185 µg/L) and Diazepam (14 µg/L). The analysis of treated hospital wastewaters showed percentage degradation of pharmaceutic pollutants (100%-43%) and significant reduction in the BOD5 (91%-68%), COD (89%-52%) and heavy metals concentrations. These strains therefore can represent a low-cost and low-tech alternative to bioremediate complex matrices of hospital wastewater prior to crop irrigation to support the achievement of clean re-usable water in developing countries like Pakistan.


Subject(s)
Alcaligenes faecalis , Environmental Pollutants , Bacillus , Bacteria , Biodegradation, Environmental , Hospitals , Wastewater
9.
Eur J Clin Microbiol Infect Dis ; 28(3): 253-9, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18752007

ABSTRACT

We sought to evaluate the safety and feasibility of inhaled aminoglycosides or colistin in cancer patients with ventilator-associated pneumonia (VAP) due to Gram-negative bacteria (GNB). A retrospective case-matched study was obtained after obtaining IRB approval in patients at the intensive care unit at our NCI-designated comprehensive cancer center between 1999 and 2005. Sixteen patients with GNB-VAP who received inhaled aminoglycosides or colistin were compared with 16 patients who had received these antibiotics intravenously alone. Eligible patients were required to have received at least six doses of inhaled therapy, or 3 or more days of intravenous therapy. Clinical Pulmonary Infection Scores were used to assess pneumonia severity. Standard ATS criteria were used to define VAP. Patients treated with inhaled antibiotics were less likely to have received corticosteroids (13% vs 50%; P < 0.02) and had a higher median baseline creatinine level (0.85 vs 0.6 mg/dL; P < 0.02) than patients treated intravenously. Pseudomonas aeruginosa (69%) was the most common cause of VAP. There were no serious adverse events associated with inhaled antibiotics. Patients who received these antibiotics intravenously developed renal dysfunction (31%); none of the patients treated with inhaled antibiotics developed nephrotoxicity (P < or = 0.04). Patients treated with inhaled antibiotics were more likely to have complete resolution of clinical (81% vs 31% in the intravenous antibiotic group; P < 0.01) and microbiologic infection (77% vs 8% in the intravenous antibiotic group: P < 0.0006). In a multivariate analysis adjusted for corticosteroid use, inhaled antibiotic therapy was predictive of complete clinical resolution (odds ratio [OR], 6.3; 95% confidence interval [CI], 1.1, 37.6; P < 0.04) and eradication of causative organisms (OR 36.7; 95% CI, 3.3, 412.2; P < 0.003). In critically ill cancer patients with Gram-negative VAP, inhaled aminoglycosides were tolerated without serious toxicity and may lead to improved outcome.


Subject(s)
Administration, Inhalation , Aminoglycosides/therapeutic use , Anti-Bacterial Agents/therapeutic use , Gram-Negative Bacterial Infections/drug therapy , Neoplasms/complications , Pneumonia, Bacterial/drug therapy , Pneumonia, Ventilator-Associated/drug therapy , Adult , Aged , Aminoglycosides/administration & dosage , Aminoglycosides/adverse effects , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Case-Control Studies , Colistin/administration & dosage , Colistin/adverse effects , Colistin/therapeutic use , Critical Illness , Drug Resistance , Female , Humans , Immunologic Factors/therapeutic use , Male , Middle Aged , Retrospective Studies , Severity of Illness Index , Steroids/therapeutic use , Treatment Outcome
10.
Bone Marrow Transplant ; 41(1): 63-7, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17934530

ABSTRACT

Post transplantation constrictive bronchiolitis (PTCB) is the most common pulmonary complication among long-term survivors of allogeneic hematopoietic stem cell transplantation (HSCT). It is a late manifestation of GVHD. Its treatment with high-dose systemic corticosteroids and other immunosuppressive regimens is associated with multiple side effects. Topical corticosteroids are used for the treatment of other manifestations of GVHD to minimize these side effects. We conducted a retrospective analysis of a series of adult patients to evaluate the efficacy of high-dose inhaled corticosteroids in the treatment of PTCB. Seventeen patients with new-onset airflow obstruction were diagnosed with PTCB. Their forced expiratory volume in 1 s (FEV1) declined from a median of 84% (range, 56-119) before HSCT to 53% (26-82) after HSCT. All patients received inhaled fluticasone propionate 500-940 microg two times daily. Symptoms of airway obstruction improved and FEV1 stabilized 3-6 months after treatment. We conclude that high-dose inhaled corticosteroids may be effective in the treatment of PTCB and propose a plausible mechanism of its action. A prospective evaluation of its efficacy is warranted.


Subject(s)
Adrenal Cortex Hormones/administration & dosage , Bronchiolitis/drug therapy , Hematopoietic Stem Cell Transplantation/adverse effects , Administration, Inhalation , Adult , Female , Graft vs Host Disease/etiology , Humans , Male , Middle Aged , Retrospective Studies
11.
Vet Clin North Am Small Anim Pract ; 48(6): 1069-1079, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30342563

ABSTRACT

This article provides a display table laying out the differential diagnosis of common acute toxicologic versus nontoxicologic illnesses in small animals. Major clinical abnormalities are listed, along with common toxicologic rule outs and nontoxicologic rule outs. Further readings are also provided.


Subject(s)
Cat Diseases/chemically induced , Cat Diseases/diagnosis , Dog Diseases/chemically induced , Dog Diseases/diagnosis , Poisoning/veterinary , Animals , Cats , Diagnosis, Differential , Dogs , Poisoning/diagnosis
12.
Vet Clin North Am Small Anim Pract ; 48(6): 1081-1085, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30342564

ABSTRACT

This article provides a quick source of information for practicing veterinarians for using various antidotes in small animal poisoning cases. For easy access, this information is included in the form of a table. The first column includes common names and/or brand names of different antidotes. In the second column, names of different toxicants or indications for which these antidotes can be used are described. The third column is the comment section that briefly describes salient points or cautions for using these antidotes.


Subject(s)
Antidotes/therapeutic use , Cat Diseases/drug therapy , Dog Diseases/drug therapy , Poisoning/veterinary , Animals , Cat Diseases/chemically induced , Cats , Dog Diseases/chemically induced , Dogs , Poisoning/drug therapy
13.
Vet Clin North Am Small Anim Pract ; 48(6): 969-984, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30149968

ABSTRACT

Nonsteroidal anti-inflammatory drugs (NSAIDs) are used for their antipyretic, anti-inflammatory, and analgesic properties. Although most NSAIDs consist of a range of pharmacologically active agents with diverse chemical structures and properties, they have similar therapeutic and adverse effects associated with their use. Each year, the American Society for the Prevention of Cruelty to Animals Animal Poison Control Center (APCC) receives hundreds of cases involving acute accidental ingestion/overdose of NSAIDs in dogs and cats. This article provides an overview on the classification, uses, pharmacokinetics, mechanisms of action, and treatment of the most commonly encountered NSAIDs in dogs and cats.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/toxicity , Cat Diseases/chemically induced , Dog Diseases/chemically induced , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Cat Diseases/drug therapy , Cat Diseases/physiopathology , Cats , Dog Diseases/drug therapy , Dog Diseases/physiopathology , Dogs
14.
Bone Marrow Transplant ; 39(3): 157-64, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17245424

ABSTRACT

Pneumocandins have concentration-dependent antifungal activity and higher dose of caspofungin (HD-CAP) in combination with other licensed antifungal therapy (OLAT) may improve response. Thirty-four patients who received HD-CAP were compared with 63 patients who received standard dose (SD)-CAP. There were no differences between the groups in either patient or disease characteristics. Significantly more patients in the HD-CAP arm had extrapulmonary infections (29 vs 8% in SD group; P=0.0053), and non-Aspergillus species infection (21 vs 6%; P=0.05) and had received prior antifungal therapy (71 vs 33%; P=0.0004). No serious adverse reactions were noted in patients receiving HD- or SD-CAP therapy. Twelve weeks after treatment commenced 44% had a complete or partial response compared with 29% in SD-CAP group (P=0.1). Logistic regression analysis showed a significant probability of a favorable outcome at 12 weeks in patients who received HD-CAP (OR 3.066, 95% CI, 1.092-8.61; P=0.033). This may in part reflect higher number of patients in HD group had received granulocyte-macrophage colony-stimulating factor (41 vs 14% in SD group; P=0.04) and/or interferon gamma (26 vs 5% in SD group; P=0.003) immune enhancement. Further studies are needed to evaluate efficacy of HD-CAP in severely immunosuppressed cancer patients with invasive fungal infections.


Subject(s)
Antifungal Agents/therapeutic use , Hematologic Neoplasms/complications , Hematologic Neoplasms/drug therapy , Hematopoietic Stem Cell Transplantation/methods , Peptides, Cyclic/administration & dosage , Adult , Aged , Antifungal Agents/toxicity , Caspofungin , Dose-Response Relationship, Drug , Drug Therapy, Combination , Echinocandins , Female , Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use , Hematologic Neoplasms/therapy , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Infections/chemically induced , Interferon-gamma/therapeutic use , Lipopeptides , Male , Middle Aged , Peptides, Cyclic/toxicity , Remission Induction , Retrospective Studies , Treatment Outcome
15.
Clin Microbiol Infect ; 13(1): 1-4, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17184281

ABSTRACT

Invasive fungal infections are common in severely immunosuppressed patients with cancer and in recipients of haematopoietic transplants. Response to antifungal therapy alone is often inadequate. Pro-inflammatory cytokines are critical for promoting innate and adaptive cellular antifungal immune responses. Recombinant cytokines, including granulocyte-macrophage-colony stimulating factor and interferon-gamma, have been studied as adjuvant therapies for severely immunosuppressed cancer patients with difficult-to-treat invasive mycoses. The limited clinical experience to date shows a possible benefit of these cytokines, and further controlled clinical trials are needed to validate their routine use in cancer patients and stem-cell transplant recipients with invasive fungal infections who are likely to have a poor response to antifungal drug therapy.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Cytokines/therapeutic use , Mycoses/drug therapy , Mycoses/etiology , Neoplasms/complications , Clinical Trials as Topic , Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use , Humans , Immunity, Cellular , Immunocompromised Host , Interferon-gamma/therapeutic use , Mycoses/immunology , Neoplasms/immunology , Recombinant Proteins/therapeutic use
16.
J Nematol ; 39(1): 50-4, 2007 Mar.
Article in English | MEDLINE | ID: mdl-19259475

ABSTRACT

Harmony grape rootstock displays resistance to several Meloidogyne spp. but that resistance is not durable in commercial vineyard settings. A 2-year experiment in a microplot setting revealed host specificities of two virulent populations of Meloidogyne arenaria and an avirulent population of Meloidogyne incognita. In a subsequent split-root experiment, the avirulent nematode population was demonstrated to induce resistance to the virulent nematode population. To quantify the level of resistance, reproduction of the virulent nematode population was determined 63 days after being challenged by an avirulent nematode population using a range of inoculum densities and timeframes. Induction of resistance became apparent when the virulent nematode population was inoculated 7 days after the avirulent nematode population and increased thereafter. The level of induced resistance increased with increased inoculum levels of the avirulent nematode population. Root systems of perennial crops are commonly fed upon simultaneously by multiple nematode species. These two studies indicate that field populations can become preferentially virulent upon one or multiple rootstocks and that co-inhabiting populations may induce existing resistance mechanisms. In perennial crops, it is common for numerous nematode species besides Meloidogyne spp. to be present, including some that feed without causing apparent damage.

17.
J Laryngol Otol ; 131(S1): S36-S40, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27786150

ABSTRACT

BACKGROUND: Nodal metastasis is an important prognostic factor in head and neck squamous cell carcinoma. This study aimed to determine the average nodal basin yield per level of neck dissection, and to investigate if age, gender, body mass index, tumour size, depth of tumour invasion and p16 status influence nodal yield. METHOD: A retrospective review of 185 patients with head and neck squamous cell carcinoma generated 240 neck dissection specimens. RESULTS: The respective mean nodal yields for levels I, II, III, IV and V were 5.27, 9.43, 8.49, 7.43 and 9.02 in non-cutaneous squamous cell carcinoma patients, and 4.2, 7.57, 9.65, 4.33 and 12.29 in cutaneous squamous cell carcinoma patients. Multiple regression analysis revealed that p16-positive patients with mucosal squamous cell carcinoma yielded, on average, 2.4 more nodes than their p16-negative peers (p = 0.04, 95 per cent confidence interval = 0.116 to 4.693). This figure was 3.84 (p = 0.008, 95 per cent confidence interval = 1.070 to 6.605) for p16-positive patients with oral cavity squamous cell carcinoma. CONCLUSION: In mucosal squamous cell carcinoma, p16-positive status significantly influenced nodal yield, with the impact being more pronounced in oral cavity squamous cell carcinoma patients.


Subject(s)
Carcinoma, Squamous Cell/pathology , Head and Neck Neoplasms/pathology , Hypopharyngeal Neoplasms/pathology , Laryngeal Neoplasms/pathology , Lymph Nodes/pathology , Mouth Neoplasms/pathology , Skin Neoplasms/pathology , Adult , Age Factors , Aged , Aged, 80 and over , Body Mass Index , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/surgery , Cohort Studies , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Female , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/surgery , Humans , Hypopharyngeal Neoplasms/metabolism , Hypopharyngeal Neoplasms/surgery , Laryngeal Neoplasms/metabolism , Laryngeal Neoplasms/surgery , Lymphatic Metastasis , Male , Middle Aged , Mouth Neoplasms/metabolism , Mouth Neoplasms/surgery , Multivariate Analysis , Neck , Neck Dissection , Neoplasm Invasiveness , Neoplasm Staging , Regression Analysis , Retrospective Studies , Sex Factors , Skin Neoplasms/metabolism , Skin Neoplasms/surgery , Squamous Cell Carcinoma of Head and Neck , Tumor Burden
18.
Bone Marrow Transplant ; 38(5): 327-37, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16915223

ABSTRACT

The challenges in the treatment of systemic fungal infections after HSCT include: (1) changing epidemiology as less drug-susceptible saprophytic fungi are increasingly associated with human disease; (2) the difficulty of early and correct diagnosis, even with the new generation of enzymatic immunoassays; (3) the inability to reduce or eliminate predisposing factors, especially severe immune suppression in most transplant patients with these infections and (4) the uncertain role of antifungal drug combinations and risk of drug antagonism complicating effective empiric-pre-emptive therapy. Current, developing and future immune enhancement strategies including recombinant granulocyte- and granulocyte macrophage-colony stimulating factor (GM-CSF), interferon-gamma (IFN-gamma), adjuvant pro-inflammatory cytokine therapy during mobilized donor granulocyte transfusions, therapeutic potential of pentraxin, adaptive immune transfer and dendritic cell fungal vaccines. Improved understanding of the molecular pathogenesis of fungal infections and of the complexity of host antifungal immune responses has provided the critical information to readdress existing treatment paradigms and further evaluate the role of GM-CSF and IFN-gamma early in the course of therapy against life-threatening fungal infections in high-risk patients following stem cell transplantation.


Subject(s)
Antifungal Agents/therapeutic use , Hematopoietic Stem Cell Transplantation/adverse effects , Immunity/physiology , Mycoses/drug therapy , Graft vs Host Disease/immunology , Granulocyte Colony-Stimulating Factor/therapeutic use , Granulocytes/transplantation , Humans , Immunity, Innate/drug effects , Immunoenzyme Techniques , Mycoses/diagnosis , Mycoses/mortality , Predictive Value of Tests
19.
FASEB J ; 19(11): 1498-500, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15985525

ABSTRACT

To search for novel transcriptional pathways that are activated in skeletal muscle after endurance exercise, we used cDNA microarrays to measure global mRNA expression after an exhaustive bout of high-intensity cycling (approximately 75 min). Healthy, young, sedentary males performed the cycling bout, and skeletal muscle biopsies were taken from the vastus lateralis before, and at 3 and 48 h after exercise. We examined mRNA expression in individual muscle samples from four subjects using cDNA microarrays, used repeated-measures significance analysis of microarray (SAM) to determine statistically significant expression changes, and confirmed selected results using real-time RT-PCR. In total, the expression of 118 genes significantly increased 3 h postcycling and 8 decreased. At 48 h, the expression of 29 genes significantly increased and 5 decreased. Many of these are potentially important novel genes involved in exercise recovery and adaptation, including several involved in 1) metabolism and mitochondrial biogenesis (FOXO1, PPARdelta, PPARgamma, nuclear receptor binding protein 2, IL-6 receptor, ribosomal protein L2, aminolevulinate delta-synthase 2); 2) the oxidant stress response (metalothioneins 1B, 1F, 1G, 1H, 1L, 2A, 3, interferon regulatory factor 1); and 3) electrolyte transport across membranes [Na+-K+-ATPase (beta3), SERCA3, chloride channel 4]. Others include genes involved in cell stress, proteolysis, apoptosis, growth, differentiation, and transcriptional activation, as well as all three nuclear receptor subfamily 4A family members (Nur77, Nurr1, and Nor1). This study is the first to characterize global mRNA expression during recovery from endurance exercise, and the results provide potential insight into 1) the transcriptional contributions to homeostatic recovery in human skeletal muscle after endurance exercise, and 2) the transcriptional contributions from a single bout of endurance exercise to the adaptive processes that occur after a period of endurance exercise training.


Subject(s)
Exercise , Muscle, Skeletal/metabolism , RNA, Messenger/analysis , Adult , Apoptosis , DNA-Binding Proteins/genetics , Electron Transport , Forkhead Box Protein O1 , Forkhead Transcription Factors/genetics , Humans , Male , Mitochondria/metabolism , Nerve Tissue Proteins/genetics , Oligonucleotide Array Sequence Analysis , Oxidative Stress , PPAR gamma/genetics , PPAR gamma/physiology , Physical Endurance , Receptors, Interleukin-6/genetics , Receptors, Steroid/genetics , Receptors, Thyroid Hormone/genetics , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Sodium-Potassium-Exchanging ATPase/genetics
20.
Clin Microbiol Infect ; 12(7): 621-6, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16774557

ABSTRACT

This study reviewed retrospectively the clinical characteristics of 28 cancer patients with fungal osteoarticular infections (FOAIs) between 1995 and 2005. Most patients (26; 93%) had haematological malignancies (19 had leukaemia); half (14) were allogeneic stem-cell transplant recipients. Twelve patients (43%) had severe neutropenia (< or = 100/mm3) with a mean duration of 65 days (range 10-500 days), and ten (36%) patients had received a significant dose of corticosteroids. Most (19; 68%) FOAIs were caused by contiguous extension, while nine (32%) were associated with haematogenous spread. Pain, joint instability and local drainage were seen in 28 (100%), six (21%), and seven (25%) patients, respectively. Sixteen (57%) patients had symptoms for < 1 month. The sinuses (ten; 36%) and the vertebral spine (six; 21%) were the most common sites involved. Moulds were the predominant pathogens: Aspergillus fumigatus (two); non-fumigatus Aspergillus spp. (eight); non-specified Aspergillus spp. (three); Fusarium spp. (six); Zygomycetes (five); Scedosporium apiospermum (two); and Exserohilum sp. (one). Candida was the causative pathogen in four cases (including two cases of mixed FOAIs). Arthritis and post-operative FOAIs were both uncommon manifestations, occurring in two patients each. All patients received systemic antifungal therapy (combinations in 20 cases), and 19 cases underwent adjunctive surgery. The crude mortality rates (at 12 weeks) were 44% (9/20) in the patients who underwent surgery and antifungal therapy vs. 33% (2/6) in patients who received antifungal therapy alone (p not significant). FOAI is a rare, yet severe, manifestation of localised or systemic mycoses, caused predominantly by moulds, and is seen typically in patients with haematological malignancies.


Subject(s)
Joint Diseases/microbiology , Mycoses/microbiology , Neoplasms/complications , Adult , Aged , Aged, 80 and over , Antifungal Agents/therapeutic use , Female , Hematologic Neoplasms/complications , Humans , Joint Diseases/drug therapy , Male , Middle Aged , Mycoses/drug therapy , Retrospective Studies , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL